Advertisement

Immunologic Research

, 9:93 | Cite as

Genetics of HLA class II regulation

  • Clifford R. Hume
  • Janet S. Lee
MHC Class II Genes and Molecules, Symposium (Part II)

Keywords

Major Histocompatibility Complex Class Phorbol Ester Mutant Cell Line Human Class Octamer Motif 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Winchester, R.J.; Kunkel, H.G.: The human Ia system. Adv. Immunol.28: 221–285 (1980).CrossRefGoogle Scholar
  2. 2.
    Radka, S.F.; Charron, D.J.; Brodsky, F.M.: Class II molecules of the major histocompatibility complex considered as differentiation markers. Hum. Immunol.16: 390–400 (1986).PubMedCrossRefGoogle Scholar
  3. 3.
    Houghton, A.N.; Thomson, T.M.; Gross, D.; Oettgen, H.G.; Old, L.J.: Surface antigens of melanoma and melanocytes—Specificity of induction of Ia antigens by human gamma-interferon. J. exp. Med.160: 255–269 (1984).PubMedCrossRefGoogle Scholar
  4. 4.
    Noelle, R.; Krammer, P.H.; Ohara, J.; Uhr, J.W.; Vitetta, E.S.: Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. Proc. natn. Acad. Sci. USA81: 6149–6153 (1984).CrossRefGoogle Scholar
  5. 5.
    Roehm, N.W.; Leibson, H.J.; Zlotnick, A.; Kappler, J.; Marrack, P.; Cambier, J.: Interleukin-induced increase in Ia expression by normal mouse B cells. J. exp. Med.160: 679–694 (1984).PubMedCrossRefGoogle Scholar
  6. 6.
    Korman, A.J.; Boss, J.M.; Spies, T.; Sorrentino, R.; Okada, K.; Strominger, J.L.: Genetic complexity and expression of human class II histocompatibility antigens. Immunol. Rev.85: 45–86 (1985).PubMedCrossRefGoogle Scholar
  7. 7.
    Gladstone, P.; Pious, D.: Stable variants affecting B cell alloantigens in human lymphoid cells. Nature271: 459–461 (1978).PubMedCrossRefGoogle Scholar
  8. 8.
    Accolla, R.S.: Human B cell variants immuno-selected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J. exp. Med.157: 1053–1058 (1983).PubMedCrossRefGoogle Scholar
  9. 9.
    Calman, A.F.; Peterlin, B.M.: Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J. Immun.139: 2489–1495 (1987).PubMedGoogle Scholar
  10. 10.
    Touraine, J.-L.; Betuel, H.; Touraine, F.: The bare lymphocyte syndrome; in Griscelli, Vossen, Progress in immunodeficiency research and therapy I, pp. 27–34 (Elsevier Science Publishers, Amsterdam 1984).Google Scholar
  11. 11.
    Gladstone, P.; Pious, D.: Identification of a transacting function regulating HLA-DR expression in a DR-negative B cell variant. Somatic Cell Genet.6: 285–298 (1980).PubMedCrossRefGoogle Scholar
  12. 12.
    Salter, R.D.; Alexander, J.; Levine, F.; Pious, D.; Cresswell, P.: Evidence for two trans-acting genes regulating HLA class II antigen expression. J. Immun.135: 4235–4238 (1985).PubMedGoogle Scholar
  13. 13.
    Long, E.O.; Mach, B.; Accolla, R.S.: Ia-negative B-cell variants reveal a coordinate regulation in the transcription of the HLA class II gene family. Immunogenetics19: 349–353 (1984).PubMedCrossRefGoogle Scholar
  14. 14.
    Lisowska Grospierre, B.; Charron, D.J.; de Preval, C.; Durandy, A.; Griscelli, C.; Mach, B.: A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J. clin. Invest.76: 381–385 (1985).PubMedCrossRefGoogle Scholar
  15. 15.
    Rijkers, G.T.; Roord, J.J.; Koning, F.; Kuis, W.; Zegers, B.J.M.: Phenotypical and functional analysis of B lymphocytes of two siblings with combined immunodeficiency and defective expression of major histocompatibility complex (MHC) class II antigens on mononuclear cells. J. clin. Immunol.7: 98–106 (1987).PubMedCrossRefGoogle Scholar
  16. 16.
    De Preval, C.; Hadam, M.R.; Mach, B.: Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency. New Engl. J. Med.318: 1295–1300 (1988).PubMedGoogle Scholar
  17. 17.
    Plaeger-Marshal, S.; Haas, A.; Clement, L.T.; Giogi, J.V.; Chen, I.S.Y.; Quan, S.G.; Gatti, R.A.; Stiehm, E.R.: Interferon-induced expression of class II major histocompatibility antigens in the MHC class II deficiency syndrome. J. clin. Immunol.8: 285–295 (1988).CrossRefGoogle Scholar
  18. 18.
    Hume, C.R.; Shookster, L.A.; Collins, N.; O’Reilly, R.; Lee, J.S.: Bare lymphocyte syndrome: altered class II expression in two B cell lines. Hum. Immunol. (in press).Google Scholar
  19. 19.
    Hume, C.R.; Lee, J.S.: Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors (submitted).Google Scholar
  20. 20.
    Accolla, R.S.; Carra, G.; Guardiola, J.: Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma. Proc. natn. Acad. Sci. USA82: 5145–5149 (1985).CrossRefGoogle Scholar
  21. 21.
    Accolla, R.S.; Scarpellino, L.; Carra, G.; Guardiola, J.: Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes. J. exp. Med.162: 1117–1133 (1985).PubMedCrossRefGoogle Scholar
  22. 22.
    Erlich, H.; Lee, J.S.; Petersen, J.W.; Bugawan, T.; DeMars, R.: Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ and part of the DP region: implications for class II gene order. Hum. Immunol.16: 205–219 (1986).PubMedCrossRefGoogle Scholar
  23. 23.
    De Preval, C.; Lisowska Grospierre, B.; Loche, M.; Griscelli, C.; Mach, B.: A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature318: 291–293 (1985).PubMedCrossRefGoogle Scholar
  24. 24.
    Yang, Z.; Accolla, R.S.; Pious, D.; Zegers, B.J.M.; Strominger, J.L.: Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines. EMBO J.7: 1965–1972 (1988).PubMedGoogle Scholar
  25. 25.
    Zegers, B.J.M.; Heynen, C.J.; Roord, J.J.; Kuis, W.; Stoop, J.W.; Ballieux, R.E.: Combined immunodeficiency with defective expression of HLA-antigens: analysis of the nature of defective monocyte-T cell interaction; in Griscelli, Vossen, Progress in immunodeficiency research and therapy I, pp. 35–42 (Elsevier Science Publishers, Amsterdam 1984).Google Scholar
  26. 26.
    Accolla, R.S.; Jotterand Bellomo, M.; Scarpellino, L.; Maffei, A.; Carra, G.; Guardiola, J.: aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression. J. exp. Med.164: 369–374 (1986).PubMedCrossRefGoogle Scholar
  27. 27.
    Albino, A.P.; Houghton, A.N.; Eisinger, M.; Lee, J.S.; Kantor, R.R.S.; Oliff, A.I.; Old, L.J.: Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses. J. exp. Med.164: 1710–1722 (1986).PubMedCrossRefGoogle Scholar
  28. 28.
    Hume, C.R.; Accolla, R.S.; Lee, J.S.: Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes. Proc. natn. Acad. Sci. USA84: 8603–8607 (1987).CrossRefGoogle Scholar
  29. 29.
    Shaw, G.; Kamen, R.: A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell46: 659–667 (1986).PubMedCrossRefGoogle Scholar
  30. 30.
    Chiu, R.; Imagawa, M.; Imbra, R.J.; Bockoven, J.R.; Karin, M.: Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters. Nature329: 648–651 (1987).PubMedCrossRefGoogle Scholar
  31. 31.
    Wasylyk, C.; Imler, J.L.; Wasylyk, B.: Transforming but not immortalizing oncogenes activate the transcription factor PEA-1. EMBO J.7: 2475–2483 (1988).PubMedGoogle Scholar
  32. 32.
    Sen, R.; Baltimore, D.: Inducibility of kappa immunoglobulin enhancer-binding protein NF-kB by a postranslational mechanism. Cell47: 921–928 (1986).PubMedCrossRefGoogle Scholar
  33. 33.
    Angel, P.; Imagawa, M.; Chiu, R.; Stein, B.; Imbra, R.J.; Rahmsdorf, H.J.; Jonat, C.; Herrlich, P.; Karin, M.: Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell49: 729–739 (1987).PubMedCrossRefGoogle Scholar
  34. 34.
    Satake, M.; Ibaraki, T.; Ito, Y.: Modulation of polyomavirus enhancer binding proteins by Haras oncogene. Oncogene3: 69–78 (1988).Google Scholar
  35. 35.
    Hai, T.; Liu, F.; Allegretto, E.A.; Karin, M.; Green, M.R.: A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1. Genes Dev2: 1216–1226 (1988).PubMedCrossRefGoogle Scholar
  36. 36.
    Farrell, P.J.; Rowe, D.T.; Rooney, C.M.; Kouzarides, T.: Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J.8: 127–132 (1989).PubMedGoogle Scholar
  37. 37.
    Maniatis, T.; Goodbourn, S.; Fischer, J.A.: Regulation of inducible and tissue-specific gene expression. Science236: 1237–1245 (1987).PubMedCrossRefGoogle Scholar
  38. 38.
    Ptashne, M.: How eukaryotic transcriptional activators work. Nature335: 683–689 (1988).PubMedCrossRefGoogle Scholar
  39. 39.
    Liou, H.-C.; Boothby, M.R.; Glimcher, L.H.: Distinct cloned class II MHC DNA binding proteins recognize the X box transcription element. Science242: 69–71 (1988).PubMedCrossRefGoogle Scholar
  40. 40.
    Mermod, N.; Williams, T.J.; Tjian, R.: Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature332: 557–561 (1988).PubMedCrossRefGoogle Scholar
  41. 41.
    Hume, C.R.: Regulation of HLA class II expression in class II negative mutant B-cell lines (Sloan-Kettering Division/Cornell University Medical College, New York 1988).Google Scholar
  42. 42.
    Miwa, K.; Doyle, C.; Strominger, J.L.: Sequence-specific interactions of nuclear factors with conserved sequences of human class II major histo-compatibility complex genes. Proc. natn. Acad. Sci. USA84: 4939–4943 (1987).CrossRefGoogle Scholar
  43. 43.
    Chodosh, L.A.; Baldwin, A.S.; Carthew, R.W.; Sharp, P.A.: Human CCAAT-binding proteins have heterologous subunits. Cell53: 11–24 (1988).PubMedCrossRefGoogle Scholar
  44. 44.
    Dorn, A.; Bollekens, J.; Staub, A.; Benoist, C.; Mathis, D.: A multiplicity of CCAAT box-binding proteins. Cell50: 863–872 (1987).PubMedCrossRefGoogle Scholar
  45. 45.
    Kim, C.G.; Barnhart, K.M.; Sheffery, M.: Purification of multiple erythroid proteins that bind the promoter of the alpha-globin gene. Mol. cell. Biol.8: 4270–4281 (1988).PubMedGoogle Scholar
  46. 46.
    Parslow, T.G.; Jones, S.D.; Bond, B.; Yamamoto, K.R.: The immunoglobulin octanucleotide: independent activity and selective interaction with enhancers. Science235: 1498–1501 (1987).PubMedCrossRefGoogle Scholar
  47. 47.
    Landolfi, N.F.; Capra, J.D.; Tucker, P.W.: Interaction of cell-type specific nuclear proteins with immunoglobulin V H promoter region sequences. Nature323: 548–551 (1986).PubMedCrossRefGoogle Scholar
  48. 48.
    Staudt, L.M.; Singh, H.; Sen, R.; Wirth, T.; Sharp, P.A.; Baltimore, D.: A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature323: 640–643 (1988).CrossRefGoogle Scholar
  49. 49.
    Sherman, P.A.; Basta, P.V.; Ting, J.P.: Upstream DNA sequences required for tissue-specific expression of the HLA-DR alpha gene. Proc. natn. Acad. Sci. USA84: 4254–4258 (1987).CrossRefGoogle Scholar
  50. 50.
    Stimac, E.; Lyons, S.; Pious, D.: Transcription of HLA class II genes in the absence of B-cell-specific octamer-binding factor. Mol. cell. Biol.8: 3734–3739 (1988).PubMedGoogle Scholar
  51. 51.
    Scheidereit, C.; Heguy, A.; Roeder, R.G.: Identification and purification of a human lymphoid-specific octamer-binding protein (OTF-2) that activates transcription of an immunoglobulin promoter in vitro. Cell51: 783–793 (1987).PubMedCrossRefGoogle Scholar
  52. 52.
    Reith, W.; Satola, S.; Herrero Sanchez, C.; Amaldi, I.; Lisowska-Grospierre, B.; Griscelli, C.; Hadam, M.R.; Mach, B.: Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell53: 897–906 (1988).PubMedCrossRefGoogle Scholar
  53. 53.
    Sloan, J.H.; Boss, J.M.: Conserved upstream sequences of human class H major histocompatibility genes enhance expression of human class II genes in wild-type but not mutant B cell lines. Proc. natn. Acad. Sci. USA85: 8186–8190 (1988).CrossRefGoogle Scholar
  54. 54.
    Pious, D.; Shoval, S.U.; Kempin, S.A.: Cis-elements governing transcription of the HLA-DR promoter in cells which differ in DR alpha expression. HLA/H2 Cloning Workshop6: A57 (1988).Google Scholar

Copyright information

© Humana Press Inc. 1990

Authors and Affiliations

  • Clifford R. Hume
    • 1
  • Janet S. Lee
    • 1
    • 2
  1. 1.Immunology ProgramMemorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.Sloan-Kettering InstituteNew York(USA)

Personalised recommendations